Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
AnGes MG
>>
Phase 2
Welcome,
Profile
Billing
Logout
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
1
2
3
4
5
6
7
8
9
10
AV-001
/ Vasomune Therap, AnGes MG
GEN0101
/ AnGes MG, TSD Japan
AG0301-COVID19
/ Takara, AnGes MG, Osaka University Graduate School of Medicine, Fresh Tracks Therap
NF-kappa-B Decoy oligonucleotide topical
(AMG0101 topical) / AnGes MG, Shionogi